Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Celebrex is Fourth Drug Pfizer Puts Into Review

NEW YORK Pfizer has started a review for its Celebrex arthritis brand, now at WPP’s J. Walter Thompson in New York, sources said. JWT won Celebrex in July 2001, when the client shifted the $70 million account from Publicis’ Leo Burnett in Chicago. JWT will likely defend the business. The shop referred calls to the client, which would only confirm reviews for the brands exiting IPG’s Deutsch: Zyrtec, Zoloft and Bextra.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in